MonitorDirect · GrowthWatch before adding
DSP Midcap Fund
DSP Mutual FundEquity Scheme - Mid Cap Fund13.8 years
The scheme aims to generate long term capital appreciation from a portfolio that is substantially constituted of equity and equity related securities of midcap companies.
- NAV
- 160.022
- 30 Oct 2026
- 1Y
- -4.4%
- Trailing CAGR
- Upside capture
- +85%
- Vs NIFTY MIDCAP 150 TRI
- Downside capture
- +87%
- Lower is better
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Prefer peers if · Prefer Baroda BNP Paribas Mid Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.85% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -32.7%. Ask whether you can hold through a similar fall.
Vs category
Watch
49% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Abhishek Ghosh · 4.2 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 30.2% of the portfolio.
Browse category
Same-category peers are preloaded into compare when available.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 33%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y-4.4%
- 3Y+12.6%
- 5Y+10.0%
- 10Y+13.0%
- SI+16.0%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-6.4%
- 3Y+3.2%
- 5Y+10.5%
- 10Y+13.4%
- Since inception
- +16.0%
- Calendar-day CAGR
- Excess 1Y
- -1.7%
- Category median, same plan and option
- 3Y win rate
- +49%
- Windows beating the median
- 3Y percentile
- 35
- Vs comparable share classes
- SIP 3Y XIRR
- +3.2%
- Simulated monthly SIP
- Worst rolling 3Y
- -4.1%
- 2656 daily-ending windows
- Median rolling 3Y
- +18.5%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 2161 daily-ending windows
Official benchmark
Date-aligned against NIFTY MIDCAP 150 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
- 1Y excess
- -0.0%
- Fund minus TRI
- 3Y excess
- -1.2%
- Fund minus TRI
- Upside capture
- +85%
- Benchmark-up months
- Downside capture
- +87%
- Lower is better
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -32.7%
- Worst peak-to-trough
- Current
- -10.4%
- Below last peak
- Current spell
- 60 days
- Days below latest peak
- Time below peak
- +88%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 17 days
- 154 recovered episodes
- Longest recovery
- 461 days
- Trough to prior peak
20 Feb 2020 – 25 Aug 2020
Trough 23 Mar 2020 · recovered in 155 days
-32.7%
8 Jan 2013 – 1 Jan 2014
Trough 28 Aug 2013 · recovered in 126 days
-28.0%
18 Oct 2021 – 17 Jul 2023
Trough 20 Jun 2022 · recovered in 392 days
-22.5%
1 Oct 2024 – 11 Feb 2026
Trough 28 Feb 2025 · recovered in 348 days
-21.2%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
35
Vs category
39
Consistency
50
Risk-adjusted
58
Drawdown
18
Mean
40
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Monitor
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
- Long-term category-relative performance remains stronger than the most recent rolling 1-year windows, which have deteriorated across multiple periods.
Supporting reads
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 65 holdings · top 10 are 30.2%.
- Top 5
- 17.7%
- Top 10
- 30.2%
- Largest holding
- 4.7%
- Effective holdings
- 48.9
Reverse Repo
Unspecified
4.7%
Coforge Ltd
Technology
4.1%
Multi Commodity Exchange Of India Ltd
Financial
3.3%
Ipca Laboratories Ltd
Healthcare
2.8%
Phoenix Mills Ltd
Real Estate
2.7%
What changed
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
30 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
29 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
28 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Baroda BNP Paribas Mid Cap Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- +0.8%
- 3Y
- +15.3%
- Vol
- 14.5%
- Max DD
- -18.6%
- Sharpe
- 0.70
- 3Y win
- +97%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
HDFC Mid Cap Fund
HDFC Mutual Fund
- 1Y
- -3.0%
- 3Y
- +15.6%
- Vol
- 15.6%
- Max DD
- -39.5%
- Sharpe
- 0.86
- 3Y win
- +76%
- Lower volatility
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Axis Midcap Fund
Axis Mutual Fund
- 1Y
- +1.3%
- 3Y
- +16.1%
- Vol
- 14.9%
- Max DD
- -29.4%
- Sharpe
- 0.82
- 3Y win
- +41%
- Lower volatility
- Shallower drawdown
- Lower TER
- Higher trailing returns
Franklin India Mid Cap Fund
Franklin Templeton Mutual Fund
- 1Y
- -8.4%
- 3Y
- +13.4%
- Vol
- 15.4%
- Max DD
- -36.6%
- Sharpe
- 0.74
- 3Y win
- +58%
- Lower volatility
- Higher win rate vs category
- Higher trailing returns
Caveat: Deeper drawdown · Higher TER
ITI Mid Cap Fund
ITI Mutual Fund
- 1Y
- -1.3%
- 3Y
- +17.7%
- Vol
- 16.4%
- Max DD
- -22.7%
- Sharpe
- 0.67
- 3Y win
- +100%
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Higher TER